David P Meeker insider trades: Rhythm Pharmaceuticals (RYTM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
and 1 more company
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | RYTM | ↓ Sell | 50,000 | $102.67 | $5.1M | Direct | Sep 14, 2026 (0d) |
| Jun 3, 2025 | RYTM | ↓ Sell | 43,620 | $65.05 | $2.8M | Direct | Jun 5, 2025 (2d) |
| Feb 19, 2025 | RYTM | ↓ Sell | 9,896 | $57.22 | $566K | Direct | Feb 19, 2025 (0d) |
| Feb 4, 2025 | RYTM | ↓ Sell | 4,278 | $59.43 | $254K | Direct | Feb 4, 2025 (0d) |
| Aug 27, 2024 | TRVI | ↓ Sell | 4,555 | $2.93 | $13K | Direct | Aug 29, 2024 (2d) |
| Mar 19, 2024 | RYTM | ↓ Sell | 45,494 | $39.22 | $1.8M | Direct | Mar 19, 2024 (0d) |
| Feb 1, 2024 | RYTM | ↓ Sell | 4,361 | $45.06 | $197K | Direct | Feb 5, 2024 (4d) |
| Mar 30, 2021 | RYTM | ↑ Buy | 10,000 | $20.17 | $202K | Direct | Mar 31, 2021 (1d) |
| May 9, 2019 | TRVI | ↑ Buy | 11,250 | $10.00 | $113K | Direct | May 13, 2019 (4d) |
| Oct 10, 2017 | RYTM | ↑ Buy | 25,000 | $17.00 | $425K | Direct | Oct 10, 2017 (0d) |
| May 25, 2010 | GENZ | ↓ Sell | 2,732 | $45.60 | $125K | Direct | May 26, 2010 (1d) |
| May 21, 2010 | GENZ | ↓ Sell | 16,488 | $49.06 | $809K | Direct | May 25, 2010 (4d) |
| Apr 23, 2009 | GENZ | ↑ Buy | 2,000 | $51.95 | $104K | Direct | Apr 24, 2009 (1d) |
| Aug 15, 2008 | GENZ | ↓ Sell | 17,790 | $83.19 | $1.5M | Direct | Aug 18, 2008 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RYTM insiders
Open-market trades in the last 12 months
About David P Meeker's insider trades
David P Meeker is President and CEO at Rhythm Pharmaceuticals (RYTM). Since Aug 15, 2008, David has reported 4 open-market purchases worth $843K and 10 sales worth $13.2M on SEC Form 4. In the last 12 months: 1 sale ($5.1M).
Their filings also include grants and awards (33 filings), option exercises (12 filings), other transactions (3 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RYTM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.